Redefining Infection Control
Antibiotics are failing.
Biofilms are winning.
We have the answer.
Unmatched Strengths that Drive
Sustainable Competitive Edge
SUPERIOR PERFORMANCE
Effective across diverse conditions and pathogen types, including MRSA and other antibiotic-resistant infections
LOWER RESISTANCE POTENTIAL
Non-antibiotic, non-toxic composition minimizes resistance risk over time
LOW TOXICITY
Formulated to minimize toxicity, allowing safe use even in sensitive areas
Mission
AZ Solutions is pioneering the future of infection control with CleanZinc™, a revolutionary zinc-chlorite antimicrobial platform that outperforms traditional treatments by up to 21,000 times. Our non-antibiotic, low-toxicity formulations eliminate biofilms, prevent antibiotic-resistant infections, and support healing across a diverse range of medical, veterinary, and consumer applications. With regulatory milestones underway and a robust product pipeline, AZ Solutions is positioned to save lives and transform healthcare in the fight against antimicrobial resistance.
When antibiotics fail,
patients lose.
There are 700,000 global deaths per year from antibiotic resistance infections with an estimated 10 million deaths by 2050.
80% of chronic infections involve biofilm barriers and render antibiotics ineffective. It is estimated that antibiotic-resistant infections will cost $100 billion globally by 2030.
Dr. Hill is an Orthopedic Surgeon and researcher, with extensive experience in clinical practice, research, and medical innovation
Dr. Derek Hill
CEO and Founder of AZ Solutions
